Cargando…

Association of circulating CXCL10 and CXCL11 with systemic sclerosis

Detalles Bibliográficos
Autores principales:	Crescioli, Clara, Corinaldesi, Clarissa, Riccieri, Valeria, Raparelli, Valeria, Vasile, Massimiliano, Del Galdo, Francesco, Valesini, Guido, Lenzi, Andrea, Basili, Stefania, Antinozzi, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241615/ https://www.ncbi.nlm.nih.gov/pubmed/29760155 http://dx.doi.org/10.1136/annrheumdis-2018-213257

Ejemplares similares

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022)

Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
por: Corinaldesi, Clarissa, et al.
Publicado: (2021)

Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts
por: Antinozzi, Cristina, et al.
Publicado: (2021)

Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
por: Di Luigi, Luigi, et al.
Publicado: (2016)

The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies
por: Di Luigi, Luigi, et al.
Publicado: (2013)

CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells
por: Pietraforte, Immacolata, et al.
Publicado: (2022)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo
por: Xu, Chen, et al.
Publicado: (2023)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
por: Fenwick, Peter S., et al.
Publicado: (2015)

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
por: Palazzo, Raffaella, et al.
Publicado: (2022)

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
por: Karason, Kristjan, et al.
Publicado: (2006)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review
por: Nazari, Alireza, et al.
Publicado: (2020)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019)

Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study Design
por: Raparelli, Valeria, et al.
Publicado: (2018)

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
por: Koch, Christian, et al.
Publicado: (2022)

The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease
por: Haghbin, Mahrokh, et al.
Publicado: (2019)

MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
por: Tworek, Damian, et al.
Publicado: (2013)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
por: Lande, Roberto, et al.
Publicado: (2020)

Correction: Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
por: Koch, Christian, et al.
Publicado: (2023)

Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer
por: Lu, Can, et al.
Publicado: (2022)

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
por: Callahan, Victoria, et al.
Publicado: (2021)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
por: Matsumoto, Ari, et al.
Publicado: (2023)

Interleukin-8, CXCL10, CXCL11 and their role in insulin resistance in adult females with subclinical hypothyroidism and prediabetes
por: Stoica, Roxana Adriana, et al.
Publicado: (2022)

Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients
por: Carvalheiro, Tiago, et al.
Publicado: (2017)

The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
por: Giannattasio, S., et al.
Publicado: (2018)

Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection
por: Hakimi, Hamid, et al.
Publicado: (2014)

Envisioning simple equitable and mobile-health solutions for complex and diverse needs of women and men with atrial fibrillation
por: Raparelli, Valeria, et al.
Publicado: (2023)

The Sex-Specific Detrimental Effect of Diabetes and Gender-Related Factors on Pre-admission Medication Adherence Among Patients Hospitalized for Ischemic Heart Disease: Insights From EVA Study
por: Raparelli, Valeria, et al.
Publicado: (2019)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
por: Wilson, Nana O., et al.
Publicado: (2011)

Platelet Response to Allergens, CXCL10, and CXCL5 in the Context of Asthma
por: Gruba, Sarah, et al.
Publicado: (2022)

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2021)

High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization
por: Schettini, Juliana Araújo de Carvalho, et al.
Publicado: (2017)

CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases–associated interstitial lung disease and interstitial pneumonia with autoimmune features
por: Kameda, Masami, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ec1agr908iu52p982u1ufvqrjp